The progresses in clinical experiences and research of propranolol in the treatment of infantile hemangiomas
LI Li
MA Lin
Abstract：Hemangiomas are the most common benign tumor of infancy, severe hemangiomas can impair vital or sensory functions or cause disfigurement, even lead to life-threatening airway compromise. Many reports have been published demonstrating the impressive effect of systemic propranolol in the management of infantile hemangiomas (IH) in recent 5 years. This paper summarizes the progresses in clinical experiences such as the protocols for initate age of systemic propranolol, the dosage, duration, efficacy and adverse effect and mechanisms of propranolol treatment of IH, so as to improve recognition and management of propranolol in treating IH.
Keywords：HemangiomasPropranololClinical experiencesMechanisms
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 361-363 )